TY - JOUR
T1 - Candida auris
T2 - Epidemiological situation, laboratory capacity and preparedness in European Union and European economic area countries, 2013 to 2017
AU - The Candida auris survey collaborative group
AU - Kohlenberg, Anke
AU - Struelens, Marc J.
AU - Monnet, Dominique L.
AU - Plachouras, Diamantis
AU - Apfalter, Petra
AU - Lass-Flörl, Cornelia
AU - Muchl, Robert
AU - Presterl, Elisabeth
AU - Willinger, Birgit
AU - Catry, Boudewijn
AU - Philipova, Ivva
AU - Budimir, Ana
AU - Hadjihannas, Linos
AU - Arendrup, Maiken Cavling
AU - Märtin, Pille
AU - Jalava, Jari
AU - Berger-Carbonne, Anne
AU - Dromer, Francoise
AU - Kurzai, Oliver
AU - Vrioni, Georgia
AU - Kontopidou, Flora
AU - Kiss, Katalin
AU - Kurcz, Andrea
AU - Ásmundsdóttir, Lena Rós
AU - Burns, Karen
AU - Moro, Maria Luisa
AU - Dimina, Elina
AU - Valinteliene, Rolanda
AU - Perrin, Monique
AU - Barbara, Christopher
AU - de Greeff, Sabine
AU - Kacelnik, Oliver
AU - Deptula, Aleksander
AU - Rodrigues, Maria do Rosário
AU - Serban, Roxana
AU - Schréterová, Eva
AU - Stefkovicova, Maria
AU - Serdt, Mojca
AU - Alastruey-Izquierdo, Ana
AU - Pemán, Javier
AU - Byfors, Sara
AU - Chryssanthou, Erja
AU - Borman, Andy
AU - Brown, Colin
AU - Guy, Rebecca
AU - Johnson, Elizabeth
AU - Reilly, Jacqui
N1 - Publisher Copyright:
© 2018, Eurosurveillance. All rights reserved.
PY - 2018/3/29
Y1 - 2018/3/29
N2 - During 2013–2017, 620 cases of Candida auris were reported in the European Union/European Economic Area – 466 (75.2%) colonisations, 110 (17.7%) bloodstream infections, 40 (6.5%) other infections and four cases (0.6%) of unknown colonisation/infection status – the majority from four large outbreaks. Survey results showed that several countries lacked laboratory capacity and/or information on the occurrence of cases at national level. To prevent further spread, adequate laboratory capacity and infection control preparedness is required in Europe.
AB - During 2013–2017, 620 cases of Candida auris were reported in the European Union/European Economic Area – 466 (75.2%) colonisations, 110 (17.7%) bloodstream infections, 40 (6.5%) other infections and four cases (0.6%) of unknown colonisation/infection status – the majority from four large outbreaks. Survey results showed that several countries lacked laboratory capacity and/or information on the occurrence of cases at national level. To prevent further spread, adequate laboratory capacity and infection control preparedness is required in Europe.
UR - https://www.scopus.com/pages/publications/85045426707
U2 - 10.2807/1560-7917.ES.2018.23.13.18-00136
DO - 10.2807/1560-7917.ES.2018.23.13.18-00136
M3 - Article
C2 - 29616608
AN - SCOPUS:85045426707
SN - 1025-496X
VL - 23
JO - Eurosurveillance
JF - Eurosurveillance
IS - 13
M1 - 18-00136
ER -
SDG 3 Good Health and Well-being